Fortune August 6, 2020
Phil Wahba

Even as the COVID-19 outbreak has chilled consumer spending in the U.S., it’s proving to be a boon for CVS Health, with coronavirus testing helping to buoy the drugstore chain’s soft retail business.

CVS Health said on Wednesday, when it raised its profit forecast for the current fiscal year, that it had administered approximately 2 million COVID-19 tests as of the end of July. And some 40% of people being tested at a CVS pharmacy were new customers. What’s more, most tests were scheduled via the CVS app and websites, likely spurring adoption of such tech tools, which are typically “sticky” and help turn users into loyal customers.

The company has also set up some 1,800 drive-thru testing...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Healthcare System, Insurance, Payer, Pharma, Pharma / Biotech, Provider, Public Health / COVID, Retail care
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
Survey Suggests Pharma Industry Still Struggling with Digital Transformation
Will Walgreens’ store closures disrupt its clinical trial aims?
340B Legal Challenges Highlight The Appetite For Innovation That Supports The Program’s Goals
How Agencies Should Decide Which Costly Drugs To Target With Government March-In Rights

Share This Article